DU 145 (人前列腺癌细胞) (STR鉴定正确)

一键复制产品信息

参考文献

• Retinoblastoma-associated protein is important for TRIM24-mediated activation of the mTOR signaling pathway through DUSP2 action in prostate cancer (2024-03-21)

  作者：Da Ren:1.Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China. ; 2.Uro-Oncology Institute of Central South University, Changsha, Hunan, 410011, China. ; Wei Li:1.Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China. ; 2.Uro-Oncology Institute of Central South University, Changsha, Hunan, 410011, China. ; Ruijiang Zeng:1.Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China. ; 2.Uro-Oncology Institute of Central South University, Changsha, Hunan, 410011, China. ; Xinlin Liu:1.Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China. ; 2.Uro-Oncology Institute of Central South University, Changsha, Hunan, 410011, China. ; Huaiyuan Liang:1.Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China. ; 2.Uro-Oncology Insti

  期刊：Retinoblastoma-associated protein is important for TRIM24-mediated activation of the mTOR signaling pathway through DUSP2 action in prostate cancer

  DOI：10.1038/s41418-024-01282-w

  影响因子 ：12.4

  引用产品： C4-2 细胞 ,  22RV1 细胞 ,  PC-3 细胞 ,  DU 145 细胞

• YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation (2024-03-09)

  作者：Xuefeng Zhao:1.Department of Biochemistry and Molecular Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ; Suli Lv:1.Department of Biochemistry and Molecular Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ; Neng Li:1.Department of Biochemistry and Molecular Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ; Qingli Zou:1.Department of Biochemistry and Molecular Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. ; Lidong Sun:1.Department of Biochemistry and Molecular Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China; Cell Architecture Research Institute, Huazhong University of Science and Technology, Wuhan, Hubei, China. Electronic addre

  期刊：YTHDF2 protein stabilization by the deubiquitinase OTUB1 promotes prostate cancer cell proliferation via PRSS8 mRNA degradation

  DOI：10.1016/j.jbc.2024.107152

  影响因子 ：4.8

  引用产品： PC-3 细胞 ,  DU 145 细胞 ,  22RV1 细胞 ,  Ham's F-12K 培养基 ,  MEM (含NEAA) 培养基 ,  RPMI-1640 培养基

• Meta-biosensor with High Q-factor Based on Wet Etching for Terahertz Detection (2024-02-27)

  作者：School of Electronic Science and Engineering, Xiamen University, Xiamen, China. Shenzhen Research Institute, Xiamen University, Shenzhen, China

  期刊：Meta-biosensor with High Q-factor Based on Wet Etching for Terahertz Detection

  DOI：10.1109/JSEN.2024.3367890

  影响因子 ：4.3

  引用产品： DU 145 细胞 ,  5637 细胞

• PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming (2024-02-24)

  作者：Yinghui Hao:1.Department of Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, China. ; Fangmei Xie:1.Department of Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, China. ; Jieyi He:1.Department of Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, China. ; Chenqiong Gu:1.Department of Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, Guangdong 510632, China. ; Ying Zhao:1.Central Laboratory of Panyu Central Hospital, Guangzhou, China. ; Wenfeng Luo:1.Central Laboratory of Panyu Central Hospital, Guangzhou, China. ; Xiaoyu Song:1.Central Laboratory of Panyu Central Hospital, Guangzhou, China. ; Jian Shen:1.Central Laboratory of Panyu Central Hospital, Guangzhou, China. ; Li Yu:1.Department of Biochemistry and Molecular Biology, School of Medicine, Jinan University, Guangzhou, Guangdong 5

  期刊：PLA inhibits TNF-α-induced PANoptosis of prostate cancer cells through metabolic reprogramming

  DOI：10.1016/j.biocel.2024.106554

  影响因子 ：4.0

  引用产品： DU 145 细胞 ,  PC-3M 细胞 ,  LNCaP clone FGC 细胞

• PEI, a new transfection method, augments the inhibitory effect of RBM5 on prostate cancer (2024-02-21)

  作者：Xijia Zhou:1.Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, China. ; Yingshu Cao:1.Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, China. ; Ranwei Li:1.Department of Urinary Surgery, The Second Hospital of Jilin University, Changchun, China. ; Xin Di:1.Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, China. ; Yanqiao Wang:1.Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, China. ; Ke Wang:1.Department of Respiratory and Critical Care Medicine, The Second Hospital of Jilin University, Changchun, China. Electronic address: wke@jlu.edu.cn. ;

  期刊：PEI, a new transfection method, augments the inhibitory effect of RBM5 on prostate cancer

  DOI：10.1016/j.bbrc.2024.149703

  影响因子 ：3.1

  引用产品： PC-3 细胞 ,  DU 145 细胞

• Accurate Visualization of Metabolic Aberrations in Cancer Cells by Temperature Mapping with Quantum Coherence Modulation Microscopy (2023-04-27)

  作者：Haitao Zhou:1.Department of Nuclear Medicine, The First Hospital of Shanxi Medical University, Collaborative Innovation Center of Molecular Imaging Precision Medical, Taiyuan, Shanxi 030001, China. ; Wei Yao:1.Department of Nuclear Medicine, The First Hospital of Shanxi Medical University, Collaborative Innovation Center of Molecular Imaging Precision Medical, Taiyuan, Shanxi 030001, China. ; Xiaotong Zhou:1.Department of Nuclear Medicine, The First Hospital of Shanxi Medical University, Collaborative Innovation Center of Molecular Imaging Precision Medical, Taiyuan, Shanxi 030001, China. ; Shuai Dong:1.State Key Laboratory of Quantum Optics and Quantum Optics Devices, Institute of Laser Spectroscopy, Collaborative Innovation Center of Extreme Optics, Shanxi University, Taiyuan, Shanxi 030006, China. ; Ruonan Wang:1.Department of Nuclear Medicine, The First Hospital of Shanxi Medical University, Collaborative Innovation Center of Molecular Imaging Precision Medical, Taiyuan, Shanxi

  期刊：Accurate Visualization of Metabolic Aberrations in Cancer Cells by Temperature Mapping with Quantum Coherence Modulation Microscopy

  DOI：10.1021/acsnano.3c00392

  影响因子 ：17.1

  引用产品： A549 [A-549] 细胞 ,  Hela 细胞 ,  Hep G2 细胞 ,  BxPC-3 细胞 ,  DU 145 细胞 ,  4T1 细胞 ,  BEAS-2B 细胞 ,  MET-5A 细胞 ,  潮霉素B溶液 (50mg/mL)

• ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003 (2023-12-04)

  作者：Yu-Peng Wu:1.Department of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, 20 Chazhong Road, Fuzhou, 350005, China. ; 2.Department of Urology, National Region Medical Centre, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China. ; Wen-Cai Zheng:1.Department of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, 20 Chazhong Road, Fuzhou, 350005, China. ; 2.Department of Urology, National Region Medical Centre, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China. ; Qi Huang:1.Department of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, 20 Chazhong Road, Fuzhou, 350005, China. ; 2.Department of Urology, National Region Medical Centre, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, 350212, China. ; Xu-Yun Huang:1.Department of U

  期刊：ND630 controls ACACA and lipid reprogramming in prostate cancer by regulating the expression of circKIF18B_003

  DOI：10.1186/s12967-023-04760-w

  影响因子 ：7.4

  引用产品： PC-3 细胞 ,  DU 145 细胞 ,  LNCaP clone FGC 细胞 ,  RWPE-1 细胞 ,  293T [HEK-293T] 细胞

• A Liquid–Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer Patients (2023-03-14)

  作者：Qi You:1.Department of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China. ; 2.Department of Urology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China. ; Jia-Yin Chen:1.Department of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China. ; 2.Department of Urology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China. ; Xiao-Hui Wu:1.Department of Urology, Urology Research Institute, The First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China. ; 2.Department of Urology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China. ; Yu-Ting Xue:1.Department of Urology, Urology Research Institute, The First Affiliated

  期刊：A Liquid–Liquid Phase Separation-Related Index Associate with Biochemical Recurrence and Tumor Immune Environment of Prostate Cancer Patients

  DOI：10.3390/ijms24065515

  影响因子 ：5.6

  引用产品： RWPE-1 细胞 ,  22RV1 细胞 ,  PC-3 细胞 ,  DU 145 细胞 ,  DU 145细胞专用培养基 ,  PC-3细胞专用培养基

• Novel gene signature for predicting biochemical recurrence-free survival of prostate cancer and PRAME modulates prostate cancer progression (2023-07-15)

  作者：Gaohaer Kadeerhan:1.National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Shenzhen 518116, China. ; Bo Xue:1.National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Shenzhen 518116, China. ; 2.Shanxi Medical University Shanxi 030012, China. ; Xiaolin Wu:1.National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Shenzhen 518116, China. ; Xiaofeng Hu:1.National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Shenzhen 518116, China. ; 2.Shanxi Medical University Shanxi 030012, China. ; Jun Tian:1.National Cancer Center/Na

  期刊：Novel gene signature for predicting biochemical recurrence-free survival of prostate cancer and PRAME modulates prostate cancer progression

  DOI：PMID:37559989

  影响因子 ：5.3

  引用产品： DU 145 细胞 ,  PC-3 细胞

• Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer (2023-07-25)

  作者：Wen Bi:1.Department of Sports Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China. ; Weiming Guo:1.Department of Sports Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China. ; Gang Fan:1.Department of Urology, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China. ; Lei Xie:1.Department of Urology, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen, China. ; Changqing Jiang:1.Department of Sports Medicine, Huazhong University of Science and Technology Union Shenzhen Hospital, The 6th Affiliated Hospital of Shenzhen University Health Science Ce

  期刊：Identification and validation of a novel overall survival prediction model for immune-related genes in bone metastases of prostate cancer

  DOI：10.18632/aging.204900

  影响因子 ：5.2

  引用产品： PC-3 细胞 ,  DU 145 细胞 ,  LNCaP clone FGC 细胞 ,  22RV1 细胞 ,  RPMI-1640 培养基

• Orthogonal Optimization, Characterization, and In Vitro Anticancer Activity Evaluation of a Hydrogen Peroxide-Responsive and Oxygen-Reserving Nanoemulsion for Hypoxic Tumor Photodynamic Therapy (2023-03-03)

  作者：Liang Hong:1.Key Laboratory of Infectious Immune and Antibody Engineering in University of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Province, School of Basic Medical Sciences/School of Biology and Engineering (School of Modern Industry for Health and Medicine), Guizhou Medical University, Guiyang 550025, China. ; 2.Immune Cells and Antibody Engineering Research Center in University of Guizhou Province, Key Laboratory of Biology and Medical Engineering, Guizhou Medical University, Guiyang 550025, China. ; Jianman Wang:1.Key Laboratory of Infectious Immune and Antibody Engineering in University of Guizhou Province, Engineering Research Center of Cellular Immunotherapy of Guizhou Province, School of Basic Medical Sciences/School of Biology and Engineering (School of Modern Industry for Health and Medicine), Guizhou Medical University, Guiyang 550025, China. ; Yi Zhou:1.Key Laboratory of Infectious Immune and Antibody Engineering in University of

  期刊：Orthogonal Optimization, Characterization, and In Vitro Anticancer Activity Evaluation of a Hydrogen Peroxide-Responsive and Oxygen-Reserving Nanoemulsion for Hypoxic Tumor Photodynamic Therapy

  DOI：10.3390/cancers15051576

  影响因子 ：5.2

  引用产品： PC-3 细胞 ,  DU 145 细胞

• A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance (2023-04-08)

  作者：Longfei Yang:1.Medical School of Nantong University, 19 Qixiu Road, Nantong, 226001, Jiangsu, China. ; 2.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, 68 Zhongshan Road, Wuxi, 214002, Jiangsu, China. ; Yuwei Zhang:1.Medical School of Nantong University, 19 Qixiu Road, Nantong, 226001, Jiangsu, China. ; 2.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, 68 Zhongshan Road, Wuxi, 214002, Jiangsu, China. ; Yifan Tang:1.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, 68 Zhongshan Road, Wuxi, 214002, Jiangsu, China. ; Yang Wang:1.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, 68 Zhongshan Road, Wuxi, 214002, Jiangsu, China. ; Peng Jiang:1.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, 68 Zhongshan Road, Wuxi, 214002, Jiangsu, China. ; Fengping Liu:1.Wuxi School of Medicine, Jiangnan University, 1800 Li

  期刊：A pan-cancer analysis of DDR1 in prognostic signature and tumor immunity, drug resistance

  DOI：10.1038/s41598-023-27975-9

  影响因子 ：4.6

  引用产品： HK-2 细胞 ,  786-O [786-0] 细胞 ,  Caki-1 细胞 ,  SV-HUC-1 细胞 ,  T24 [T-24] 细胞 ,  5637 细胞 ,  RWPE-1 细胞 ,  PC-3 细胞 ,  DU 145 细胞 ,  DMEM高糖 培养基 ,  RPMI-1640 培养基 ,  Ham's F-12K 培养基 ,  人前列腺上皮细胞完全培养基

• USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma (2023-07-26)

  作者：Dewang Fu:1.Department of Urology Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, P.R. China. ; Qingyue Si:1.Department of Urology Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, P.R. China. ; Chenxi Yu:1.Department of Urology Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, P.R. China. ; Zhifu Han:1.Department of Urology Surgery, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, P.R. China. ; Li'e Zang:1.Department of Neurology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, P.R. China. ;

  期刊：USF1-mediated ALKBH5 stabilizes FLII mRNA in an m6A-YTHDF2-dependent manner to repress glycolytic activity in prostate adenocarcinoma

  DOI：10.1002/mc.23609

  影响因子 ：4.6

  引用产品： 22RV1 细胞 ,  DU 145 细胞 ,  PC-3M 细胞 ,  VCaP 细胞

• YAP1 inhibits RSL3-induced castration-resistant prostate cancer cell ferroptosis by driving glutamine uptake and metabolism to GSH (2023-09-29)

  作者：Xian Fu:1.Department of Urology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China. ; Hongshen Wu:1.Department of Urology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China. ; Changjiu Li:1.Department of Urology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China. ; Gang Deng:1.Department of Urology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China. ; Chao Chen:1.Department of Urology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou, China. andy-2222@163.com. ;

  期刊：YAP1 inhibits RSL3-induced castration-resistant prostate cancer cell ferroptosis by driving glutamine uptake and metabolism to GSH

  DOI：10.1007/s11010-023-04847-4

  影响因子 ：4.3

  引用产品： PC-3 细胞 ,  Ham's F-12K 培养基 ,  特级胎牛血清 ,  DU 145 细胞 ,  MEM (含NEAA) 培养基

• Analyzing roles of small nucleolar RNA host gene 25 from clinical, molecular target and tumor formation in prostate cancer (2023-06-10)

  作者：Zelin Liu:1.Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China; Britton Chance Center for Biomedical Photonics, Wuhan National Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan, 430074, China. ; Shuai Ke:1.Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. ; Qinghua Wang:1.Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. ; Xuhang Gu:1.School of Minerals Processing and Bioengineering, Central South University, Changsha, 410000, China. ; Guanzhong Zhai:1.Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. ; Haoren Shao:1.Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. ; Mu He:1.Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. ; Jia Guo:1.Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China. Electronic address: doctor_zelin@hust.edu

  期刊：Analyzing roles of small nucleolar RNA host gene 25 from clinical, molecular target and tumor formation in prostate cancer

  DOI：10.1016/j.yexcr.2023.113686

  影响因子 ：3.7

  引用产品： PC-3 细胞 ,  LNCaP clone FGC 细胞 ,  DU 145 细胞 ,  WPMY-1 细胞

• A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer (2023-02-24)

  作者：Lei Ren:1.Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China. ; Xu Yang:1.Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China. ; Weifeng Wang:1.Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China. ; Hansen Lin:1.Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China. ; Guankai Huang:1.Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China. ; Zixiong Liu:1.Department of Urology, The Seventh Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Shenzhen, China. ; Jincheng Pan:1.Department of Urology, The First Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen University, Guangzhou, China. ; Xiaopeng Mao:1.Department of Ur

  期刊：A cuproptosis-related LncRNA signature: Integrated analysis associated with biochemical recurrence and immune landscape in prostate cancer

  DOI：10.3389/fgene.2023.1096783

  影响因子 ：3.7

  引用产品： PC-3 细胞 ,  DU 145 细胞 ,  LNCaP clone FGC 细胞 ,  RWPE-1 细胞

• Crafting a Personalized Prognostic Model for Malignant Prostate Cancer Patients Using Risk Gene Signatures Discovered through TCGA-PRAD Mining, Machine Learning, and Single-Cell RNA-Sequencing (2023-06-07)

  作者：Feng Lyu:1.Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China. ; Xianshu Gao:1.Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China. ; Mingwei Ma:1.Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China. ; Mu Xie:1.Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China. ; Shiyu Shang:1.Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China. ; 2.First Clinical Medical School, Hebei North University, Zhangjiakou 075000, China. ; Xueying Ren:1.Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China. ; Mingzhu Liu:1.Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China. ; Jiayan Chen:1.Department of Radiation Oncology, Peking University First Hospital, Beijing 100034, China. ;

  期刊：Crafting a Personalized Prognostic Model for Malignant Prostate Cancer Patients Using Risk Gene Signatures Discovered through TCGA-PRAD Mining, Machine Learning, and Single-Cell RNA-Sequencing

  DOI：10.3390/diagnostics13121997

  影响因子 ：3.6

  引用产品： C4-2 细胞 ,  22RV1 细胞 ,  DU 145 细胞 ,  PC-3 细胞

• A Prognostic Model for Prostate Cancer Patients Based on Two DNA Damage Response Mutation-Related Immune Genes (2023-08-22)

  作者：Jian Wang:1.Department of Urology Surgery, The First People's Hospital of Foshan, Affiliated Hospital of Sun Yat-sen University, Foshan City, China. ; Li Jiang:1.Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. ; Zhenhua Shang:1.Department of Urology, Xuan Wu Hospital Capital Medical University, Beijing, China. ; Zhaohua Ye:1.Department of Urology Surgery, The People's Hospital of Dongguan, Dongguan City, China. ; Dan Yuan:1.Department of Urology, Jiangmen Central Hospital, Jiangmen, China. ; Xin Cui:1.Department of Urology, Xuan Wu Hospital Capital Medical University, Beijing, China. ;

  期刊：A Prognostic Model for Prostate Cancer Patients Based on Two DNA Damage Response Mutation-Related Immune Genes

  DOI：10.1089/cbr.2023.0033

  影响因子 ：3.4

  引用产品： DU 145 细胞 ,  LNCaP clone FGC 细胞

• Sennoside A induces autophagic death of prostate cancer via inactivation of PI3K/AKT/mTOR axis (2023-09-23)

  作者：Shaoyi Qiao:1.Department of Urology, Xijing 986 Hospital Department, Fourth Military Medical University, Xi'an, Shaanxi, 710054, China. ; Wuhe Zhang:1.Department of Urology, Xijing 986 Hospital Department, Fourth Military Medical University, Xi'an, Shaanxi, 710054, China. Zhangwuheuro@21cn.com. ; Yao Jiang:1.Department of Urology, Xijing 986 Hospital Department, Fourth Military Medical University, Xi'an, Shaanxi, 710054, China. ; Yansheng Su:1.Department of Urology, Xijing 986 Hospital Department, Fourth Military Medical University, Xi'an, Shaanxi, 710054, China. ;

  期刊：Sennoside A induces autophagic death of prostate cancer via inactivation of PI3K/AKT/mTOR axis

  DOI：10.1007/s10735-023-10156-3

  影响因子 ：3.2

  引用产品： DU 145 细胞 ,  PC-3 细胞 ,  Ham's F-12K 培养基 ,  MEM (含NEAA) 培养基 ,  特级胎牛血清 ,  青霉素-链霉素溶液 (双抗)，100×

• Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer (2023-04-12)

  作者：Qingfu Zhang:1.Department of Urology, Tai 'an Central Hospital, Tai 'an, Shandong, China. ; Peng Zhang:1.Department of Spine Surgery, Tai 'an Central Hospital, Tai 'an, Shandong, China. ; Zhongting Zhao:1.Department of Spinal Surgery, The Third People's Hospital of Jinan, Jinan, Shandong, China. ; Jun Wang:1.Department of Emergency, Qingdao Eighth People's Hospital, Qingdao, China. ; Hepeng Zhang:1.Department of Urology, Tai 'an Central Hospital, Tai 'an, Shandong, China. ;

  期刊：Exploring the role of differentially expressed metabolic genes and their mechanisms in bone metastatic prostate cancer

  DOI：10.7717/peerj.15013

  影响因子 ：2.7

  引用产品： PC-3 细胞 ,  DU 145 细胞 ,  LNCaP clone FGC 细胞 ,  22RV1 细胞

• Circ_0005276 Promotes Prostate Cancer Progression Through the Crosstalk of miR-128-3p/DEPDC1B Axis (2023-03-13)

  作者：Wenwei Li:1.Department of Urology WardIII, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Healthcare Group, No.293, Feiyun Street, Huangshi, 435000, Hubei Province, China. ; 2.Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention, Wuhan, China. ; Wenbing Wu:1.Department of Urology WardIII, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Edong Healthcare Group, No.293, Feiyun Street, Huangshi, 435000, Hubei Province, China. hszxyy1193868501@163.com. ; 2.Hubei Key Laboratory of Kidney Disease Pathogenesis and Intervention, Wuhan, China. hszxyy1193868501@163.com. ;

  期刊：Circ_0005276 Promotes Prostate Cancer Progression Through the Crosstalk of miR-128-3p/DEPDC1B Axis

  DOI：10.1007/s10528-022-10328-y

  影响因子 ：2.4

  引用产品： LNCaP clone FGC 细胞 ,  DU 145 细胞 ,  RPMI-1640 培养基 ,  特级胎牛血清 ,  RWPE-1 细胞 ,  K-SFM 培养基 ,  EGF/Urogastrone/URG, Human, Recombinant

• TRPM2-L Participates in the Interleukin-6 Pathway to Enhance Tumor Growth in Prostate Cancer by Hypoxia-Inducible Factor-1α (2023-11-10)

  作者：Kai Cheng:1.Department of Biology, College of Arts and Sciences, Central Mindanao University, Musuan, Philippines. ; 2.School of Pharmacy (School of Wine), Binzhou Medical University, Binzhou, China. ; Qingmei Jia:1.School of Public Health and Management, Binzhou Medical University, Binzhou, China. ; Christopher Batbatan:1.Department of Biology, College of Arts and Sciences, Central Mindanao University, Musuan, Philippines. ; Zhihua Guo:1.College of Biological and Food Engineering, Suzhou University, Suzhou, China. ; Fengtao Cheng:1.Department of Urology, Binzhou Central Hospital, Binzhou, China. ;

  期刊：TRPM2-L Participates in the Interleukin-6 Pathway to Enhance Tumor Growth in Prostate Cancer by Hypoxia-Inducible Factor-1α

  DOI：10.1089/jir.2023.0088

  影响因子 ：2.3

  引用产品： PC-3 细胞 ,  DU 145 细胞 ,  HUVECs cell

• Inhibitory function of CDK12i combined with WEE1i on castration-resistant prostate cancer cells in vitro and in vivo (2023-08-08)

  作者：Zheng Qin: 1.Department of Oncology, The Second Hospital of Tianjin Medical University, Tianjin, China; Dongze Liu: 1.Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China; Yueyao Zhang: 1.Department of Pathology, Tianjin Medical University, Tianjin, China; Xiaoxu Chen: 1.Department of Oncology, The Second Hospital of Tianjin Medical University, Tianjin, China; Xiao Zhu: 1.Department of Oncology, The Second Hospital of Tianjin Medical University, Tianjin, China; Shengxian Xu: 1.Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China; Baolong Peng: 1.Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin, China; Shiqiang Dong: 1.Department of Oncology, The Second Hospital of Tianjin Medical University, Tianjin, China; Dingkun Hou: 1.Department of Oncology, The Second Hospital of Tianjin Medical University, Tianjin, China; Liang Zhu: 1.Department of Urology, The Second Hospital of Tianjin Medic

  期刊：Inhibitory function of CDK12i combined with WEE1i on castration-resistant prostate cancer cells in vitro and in vivo

  DOI：10.1515/oncologie-2023-0233

  影响因子 ：0.9

  引用产品： PC-3 细胞 ,  DU 145 细胞

• Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis. (2022-09-21)

  作者：Longfei Yang:1.Medical School of Nantong University, Nantong, China. ; 2.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China. ; Yuwei Zhang:1.Medical School of Nantong University, Nantong, China. ; 2.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China. ; Yang Wang:1.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China. ; Peng Jiang:1.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China. ; Fengping Liu:1.Wuxi School of Medicine, Jiangnan University, Wuxi, China. ; Ninghan Feng:1.Medical School of Nantong University, Nantong, China. ; 2.Department of Urology, Affiliated Wuxi No. 2 Hospital of Nanjing Medical University, Wuxi, China. ;

  期刊：Ferredoxin 1 is a cuproptosis-key gene responsible for tumor immunity and drug sensitivity: A pan-cancer analysis.

  DOI：10.3389/fphar.2022.938134

  影响因子 ：6.0

  引用产品： SV-HUC-1 细胞 ,  T24 [T-24] 细胞 ,  5637 细胞 ,  HK-2 细胞 ,  786-O [786-0] 细胞 ,  Caki-1 细胞 ,  RWPE-1 细胞 ,  PC-3 细胞 ,  DU 145 细胞 ,  Ham's F-12K 培养基 ,  DMEM高糖 培养基 ,  人前列腺上皮细胞完全培养基 ,  RPMI-1640 培养基

• GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer (2022-10-25)

  作者：Ming Yang:1.The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. ; Xudong Zhu:1.The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. ; Yang Shen:1.The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. ; Qi He:1.The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. ; Yuan Qin:1.The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. ; Yiqun Shao:1.Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China. ; Lin Yuan:1.Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. ; Hesong Ye:1.The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. ;

  期刊：GPX2 predicts recurrence-free survival and triggers the Wnt/β-catenin/EMT pathway in prostate cancer

  DOI：10.7717/peerj.14263

  影响因子 ：3.1

  引用产品： PC-3 细胞 ,  DU 145 细胞 ,  LNCaP clone FGC 细胞 ,  22RV1 细胞

• Circ_0044516 Enriches the Level of SARM1 as a miR-330-5p Sponge to Regulate Cell Malignant Behaviors and Tumorigenesis of Prostate Cancer (2001-02-20)

  作者：Yan Wu:1.Department of Urology, Section 4, People's Hospital of Hunan Province, No.89, Guhan Road, Furong District, Changsha, 410002, Hunan, China. vmm77dk@163.com. ;

  期刊：Circ_0044516 Enriches the Level of SARM1 as a miR-330-5p Sponge to Regulate Cell Malignant Behaviors and Tumorigenesis of Prostate Cancer

  DOI：10.1007/s10528-021-10160-w

  影响因子 ：2.4

  引用产品： DU 145 细胞 ,  LNCaP clone FGC 细胞 ,  DMEM高糖完全培养基 (含10%FBS) ,  RPMI-1640完全培养基 (含10%FBS) ,  RWPE-1 细胞

• LOC100996425 acts as a promoter in prostate cancer by mediating hepatocyte nuclear factor 4A and the AMPK/mTOR pathway (2008-01-20)

  作者：Xiuyan Wang:1.Department of Urology, The Second Hospital of Jilin University, Changchun, China. ; Bin Song:1.Department of Neurosurgery, The Second Hospital of Jilin University, Changchun, China. ; Mingcui Zang:1.Department of Hepatobiliary and Pancreatic Surgery I, The First Hospital of Jilin University, Changchun, China. ; He Ji:1.Department of Gynaecology, The Second Hospital of Jilin University, Changchun, China. ; He Yang:1.Department of Urology, The Second Hospital of Jilin University, Changchun, China. ; Shuang Jiang:1.Department of Urology, The Second Hospital of Jilin University, Changchun, China. ; Xiao Yang:1.Department of Urology, The Second Hospital of Jilin University, Changchun, China. ;

  期刊：LOC100996425 acts as a promoter in prostate cancer by mediating hepatocyte nuclear factor 4A and the AMPK/mTOR pathway

  DOI：10.1111/jcmm.16657

  影响因子 ：5.3

  引用产品： C4-2 细胞 ,  PC-3 细胞 ,  22RV1 细胞 ,  LNCaP clone FGC 细胞 ,  DU 145 细胞

• MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways (2011-01-20)

  作者：Sihai Zhou:1.Department of Urology, The Second Affiliated Hospital of Dalian Medical University, DaLian, China. ; Zhihong Dai:1.Department of Urology, The Second Affiliated Hospital of Dalian Medical University, DaLian, China. ; Liang Wang:1.Department of Urology, The Second Affiliated Hospital of Dalian Medical University, DaLian, China. ; Xiang Gao:1.Department of Urology, The Second Affiliated Hospital of Dalian Medical University, DaLian, China. ; Liqin Yang:1.Department of Urology, The Second Affiliated Hospital of Dalian Medical University, DaLian, China. ; Zhenwei Wang:1.Department of Urology, Guangdong Second Provincial General Hospital, Guangzhou, China. ; Qi Wang:1.Department of Respiratory Medicine, The Second Affiliated Hospital of Dalian Medical University, DaLian, China. ; Zhiyu Liu:1.Department of Urology, The Second Affiliated Hospital of Dalian Medical University, DaLian, China. ;

  期刊：MET inhibition enhances PARP inhibitor efficacy in castration-resistant prostate cancer by suppressing the ATM/ATR and PI3K/AKT pathways

  DOI：10.1111/jcmm.17037

  影响因子 ：5.3

  引用产品： DU 145 细胞 ,  PC-3 细胞 ,  LNCaP clone FGC 细胞 ,  22RV1 细胞

• Identification of evodiamine as a suppressor of prostate cancer progression by reducing AR transcriptional activity via targeting Src (2010-01-20)

  作者：Pei Cheng:1.Department of Urinary Surgery, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, PR China. ; Xiaofan Zhang:1.Department of Urinary Surgery, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, PR China. ; Xiaofu Wang:1.Department of Urinary Surgery, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, PR China. ; Changwei Liu:1.Department of Urinary Surgery, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, PR China. ; Xinghua Zhao:1.Department of Urinary Surgery, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, PR China. ; Junfang Fan:1.Department of Urinary Surgery, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, PR China. ; Changbao Xu:1.Department of Urinary Surgery, the Second Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, PR China. Changbao4375@163.com. ;

  期刊：Identification of evodiamine as a suppressor of prostate cancer progression by reducing AR transcriptional activity via targeting Src

  DOI：10.1007/s12020-021-02907-7

  影响因子 ：3.9

  引用产品： PC-3 细胞 ,  DU 145 细胞

• Hsa_circ_0074032 promotes prostate cancer progression through elevating homeobox A1 expression by serving as a microRNA-198 decoy (2011-01-20)

  作者：Chuanshun Feng:1.Department of Urology, Shenzhen Longhua District Central Hospital, Shenzhen City, China. ; Qinjun Wang:1.Department of Urology, Shenzhen Longhua District Central Hospital, Shenzhen City, China. ; Ling Deng:1.Department of Urology, Shenzhen Longhua District Central Hospital, Shenzhen City, China. ; Naixiong Peng:1.Department of Urology, Shenzhen Longhua District Central Hospital, Shenzhen City, China. ; Minlong Yang:1.Department of Urology, Shenzhen Longhua District Central Hospital, Shenzhen City, China. ; Xisheng Wang:1.Department of Urology, Shenzhen Longhua District Central Hospital, Shenzhen City, China. ;

  期刊：Hsa_circ_0074032 promotes prostate cancer progression through elevating homeobox A1 expression by serving as a microRNA-198 decoy

  DOI：10.1111/and.14312

  影响因子 ：2.4

  引用产品： LNCaP clone FGC 细胞 ,  PC-3 细胞 ,  DU 145 细胞 ,  RPMI-1640 培养基 ,  Ham's F-12K 培养基 ,  MEM (含NEAA) 培养基 ,  特级胎牛血清 ,  青霉素-链霉素溶液 (双抗)，100× ,  RWPE-1 细胞 ,  RWPE-1细胞专用培养基

• Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration‑resistant prostate cancer (2011-00-20)

  作者：Mingqiu Hu:1.Department of Urology, The Second Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233040, P.R. China. ; Jing Ning:1.Department of Urology, The Second Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233040, P.R. China. ; Likai Mao:1.Department of Urology, The Second Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233040, P.R. China. ; Yuanyuan Yu:1.Department of Urology, The Second Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233040, P.R. China. ; Yu Wu:1.Department of Urology, The Second Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui 233040, P.R. China. ;

  期刊：Antitumour activity of TH1579, a novel MTH1 inhibitor, against castration‑resistant prostate cancer

  DOI：10.3892/ol.2020.12324

  影响因子 ：2.9

  引用产品： C4-2 细胞 ,  PC-3 细胞 ,  DU 145 细胞

• Hispidulin inhibits proliferation, migration, and invasion by promoting autophagy via regulation of PPARγ activation in prostate cancer cells and xenograft models (2012-00-20)

  作者：Yuanyuan Wang:1.Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China. ; Shanqi Guo:1.Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China. ; Yingjie Jia:1.Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China. ; Xiaoyu Yu:1.Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China. ; Ruiyu Mou:1.Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China. ; Xiaojiang Li:1.Department of Oncology, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, China. ;

  期刊：Hispidulin inhibits proliferation, migration, and invasion by promoting autophagy via regulation of PPARγ activation in prostate cancer cells and xenograft models

  DOI：10.1093/bbb/zbaa108

  影响因子 ：1.6

  引用产品： DU 145 细胞 ,  VCaP 细胞

• Silencing of MALAT1 inhibits migration and invasion by sponging miR‑1‑3p in prostate cancer cells (2008-09-20)

  作者：Xiaofan Dai:1.Department of Andrology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China. ; Zuowen Liang:1.Human Sperm Bank of Jilin Province, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China. ; Lingyun Liu:1.Department of Andrology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China. ; Kaimin Guo:1.Department of Andrology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China. ; Shengqi Xu:1.Department of Andrology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China. ; Hongliang Wang:1.Department of Andrology, The First Hospital of Jilin University, Changchun, Jilin 130021, P.R. China. ;

  期刊：Silencing of MALAT1 inhibits migration and invasion by sponging miR‑1‑3p in prostate cancer cells

  DOI：10.3892/mmr.2019.10602

  影响因子 ：3.4

  引用产品： 293T [HEK-293T] 细胞 ,  DU 145 细胞 ,  DU 145细胞专用培养基 ,  PC-3 细胞 ,  PC-3细胞专用培养基

• Silencing of lncRNA MALAT1 inhibits cell cycle progression via androgen receptor signaling in prostate cancer cells (2001-09-20)

  作者：Xiaofan Dai:1.Department of Andrology, The First Hospital of Jilin University, Changchun, 130021, People's Republic of China. ; Lingyun Liu:1.Department of Andrology, The First Hospital of Jilin University, Changchun, 130021, People's Republic of China. ; Zuowen Liang:1.Human Sperm Bank of Jilin Province, The First Hospital of Jilin University, Changchun, 130021, People's Republic of China. ; Kaimin Guo:1.Department of Andrology, The First Hospital of Jilin University, Changchun, 130021, People's Republic of China. ; Shengqi Xu:1.Department of Andrology, The First Hospital of Jilin University, Changchun, 130021, People's Republic of China. ; Hongliang Wang:1.Department of Andrology, The First Hospital of Jilin University, Changchun, 130021, People's Republic of China. Electronic address: whongliang2015@163.com. ;

  期刊：Silencing of lncRNA MALAT1 inhibits cell cycle progression via androgen receptor signaling in prostate cancer cells

  DOI：10.1016/j.prp.2019.01.011

  影响因子 ：2.8

  引用产品： DU 145 细胞 ,  MEM (含NEAA) 培养基 ,  PC-3 细胞 ,  Ham's F-12K 培养基

点击展开收起列表